ALLK: allakos.com Kompaniya qiymatining sof foydaga nisbati
Allakos Inc. (ALLK) uchun tarixiy P/E koeffitsiyenti narx dinamikasi -0.40 darajasida turibdi. Biznes immun patologiyalari uchun davolash vositalarini ishlab chiqishga tayanadi, bunda o'sish FDA ning qat'iy nazorati va aksiyadorlarning beqaror qiziqishi bilan cheklangan. Rahbariyat sinovlar jarayoni bo'yicha shaffof ma'lumotlar taqdim etmoqda, garchi yangi yo'nalishlarni aniqlash qiyin bo'lib qolayotgan bo'lsa-da. Bunday dori vositalariga bo'lgan talab inqirozlarga chidamli, foyda esa klinik sinovlarning muvaffaqiyatiga bog'liqdir.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_ALLK_-_Allakos-Inc._-_PE-Multiple "ALLK: Allakos Therapeutics Biznesning o‘zini qoplash muddati 04.07.2022 - 24.05.2025 | 👁️GURU.Markets👁️")
Allakos Inc (ALLK) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Allakos Inc.|ALLK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Allakos Therapeutics|ALLK - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Allakos Inc.|ALLK - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Allakos|Tezkor likvidlik koeffitsiyenti allakos.com
- foyda va bozor multiplikatorlari tafsilotlari:
ALLK - Kompaniyaning sof foydasi|Kutilayotgan foyda Allakos Inc.|ALLK - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Allakos Therapeutics|ALLK - PEG multiplikatori|EV/EBITDA multiplikatori Allakos Inc.|ALLK - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Allakos|ALLK - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi allakos.com|ALLK - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Allakos Inc.
Kompaniyaning har tomonlama tahlili:allakos.com ALLK
Innovatsion antitelalarning ishlab chiqilishi va AK006 ingibitori bo'yicha erishilgan yutuqlar Allakos Inc. (ALLK) uchun yuqori ichki qiymat yaratadi. Kompaniyaning joriy P/E koeffitsiyenti bozor kapitalizatsiyasi va sof foyda o'rtasidagi bog'liqlikni aks ettirib, investitsiya qilingan kapitalning zichligini o'lchaydi. Ushbu koeffitsiyent dinamikasini tahlil qilish biotexnologiya biznesining yetuklik darajasini baholash imkonini beradi. Chiziq barqarorligi tashqi zarbalarga chidamlilikni tasdiqlaydi, uzoq davom etgan tekis tendentsiya esa stagnatsiyadan dalolat beradi. Bu esa emitentning yirik sog'liqni saqlash gigantlari tomonidan sotib olinish potentsialini belgilaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|TRML - P/E multiplikatori|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|PHAR (pharming.com) - Narxning foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narxning foydaga nisbati UPB|P/E multiplikatori ZBIO|P/E multiplikatori Immunome Bio (IMNM)|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|P/E multiplikatori kalvista.com KALV|SEPN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Pieris Pharma|Savara Corp (SVRA) - Narxning foydaga nisbati|RIGL - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ANAB|ATXS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENGN|Biznesning o‘zini qoplash muddati RAPT Therapeutics Inc.|Narxning foydaga nisbati Aerovate Therapeutics JBIO|ACRS: Narx-foyda multiplikatori|Kyverna Therapeutics - P/E multiplikatori|tizianalifesciences.com (TLSA) - Narx-foyda koeffitsiyenti|CABA (Cabaletta Bio) - Narx-foyda koeffitsiyenti|VTYX - Biznesning o‘zini qoplash muddati|THTX (Theratechnologies Inc) - P/E multiplikatori|P/E multiplikatori Avalo Therapeutics Inc|Narxning foydaga nisbati Eledon Pharmaceuticals (ELDN)|Narxning foydaga nisbati AGEN (agenusbio.com)|Narxning foydaga nisbati Climb Bio CLYM|Zura Bio Ltd - Narxning foydaga nisbati|ATYR - Narxning foydaga nisbati|ADAG - P/E multiplikatori|ikenaoncology.com (IMA) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati STTK (Shattuck Labs)|EQ (Equillium Inc) - P/E multiplikatori|CNTB: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori IMUX|P/E multiplikatori atarabio.com (ATRA)|Narxning foydaga nisbati InflaRx IFRX|Kompaniya qiymatining sof foydaga nisbati XFOR|ACET - Narxning foydaga nisbati|Celularity Inc. (CELU) - Narx-foyda koeffitsiyenti|INMB: P/E multiplikatori|Barinthus Biotherapeutics Corp (BRNS) - P/E multiplikatori|Narx-foyda koeffitsiyenti KZR|SABS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AKTX|Biznesning o‘zini qoplash muddati enlivex.com|Narxning foydaga nisbati Q32 Bio QTTB|GOVX - Narx-foyda koeffitsiyenti|EDSA - Narxning foydaga nisbati|ibioinc.com (IBIO) - Narx-foyda koeffitsiyenti|CARM (carismatx.com) - Narx-foyda koeffitsiyenti|XTL Biopharmaceuticals Ltd (XTLB) - P/E multiplikatori|Narxning foydaga nisbati Bolt Biotherapeutics Inc.|Narx-foyda multiplikatori HCWB (HCW Biologics Inc)|P/E multiplikatori APVO|AIM - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ADTX (Aditxt, Inc.)|P/E multiplikatori GRI Bio Inc GRI|XRTX - Narxning foydaga nisbati|HIND: Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narxning foydaga nisbati|INDP (indaptusrx.com) - Narxning foydaga nisbati|SCNI (Scinai Immunotherapeutics Ltd.) - P/E multiplikatori|P/E multiplikatori CalciMedica Corp|Narxning foydaga nisbati Affimed (AFMD)|P/E multiplikatori hookipapharma.com (HOOK)|Narxning foydaga nisbati IGM Biosciences IGMS|iteostherapeutics.com (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati TC BioPharm (Holdings) Plc TCBP|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
